Lataa...
Identification of an orally available compound with potent and broad FLT3 inhibition activity
FLT3 internal tandem duplication (FLT3-ITD) is an activating mutation found in 20%-30% of patients with acute myeloid leukemia (AML), which makes FLT3 an attractive target for the treatment of AML. Although FLT3-mutant patients respond to current FLT3 inhibitors, relapse usually happens due to the a...
Tallennettuna:
| Julkaisussa: | Oncogene |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4809803/ https://ncbi.nlm.nih.gov/pubmed/26411368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2015.362 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|